FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $74,300 | -50.6% | 13,035 | -12.6% | 0.11% | -43.8% |
Q4 2022 | $150,462 | -64.6% | 14,912 | -21.3% | 0.19% | -54.1% |
Q3 2022 | $425,000 | -12.0% | 18,946 | -2.7% | 0.42% | -5.9% |
Q2 2022 | $483,000 | -39.8% | 19,474 | -5.9% | 0.44% | +1.8% |
Q1 2022 | $802,000 | -15.0% | 20,697 | +28.3% | 0.44% | +32.9% |
Q4 2021 | $944,000 | +9.9% | 16,138 | +11.3% | 0.33% | +14.3% |
Q3 2021 | $859,000 | -57.3% | 14,494 | -37.6% | 0.29% | -61.2% |
Q2 2021 | $2,014,000 | +11.7% | 23,211 | +6.1% | 0.74% | -8.1% |
Q1 2021 | $1,803,000 | -15.3% | 21,867 | -6.6% | 0.80% | -23.0% |
Q4 2020 | $2,128,000 | – | 23,407 | – | 1.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |